Abbott reports results: Abbott Laboratories stock trades 0.56 percent above EUR 91.88 Xetra close

Published on 10/25/2026 at 17:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Abbott Laboratories stock trades in weekend trading at EUR 92.39 on October 25, 2026, 0.56 percent above the Xetra close of EUR 91.88. Results came October 21.

Results and trading context

Abbott reported third-quarter 2026 sales of $13.013 billion on October 21, 2026.
Abbott Laboratories stock trades in weekend trading at EUR 92.39, 0.56 percent above the Xetra close of October 23, 2026, at EUR 91.88.
The next Xetra session is October 26, 2026.

Pharma-Campus Architektur-Render Abbott Laboratories US0028241000 Illinois — Abbott Laboratories US0028241000 Architektur-Render moderner Pharma-Campus mit Glas-Stahl-Gebäuden Grünanlagen und Teich Illinois, Illustration mit AI erstellt.

Abbott Laboratories reported third-quarter 2026 results on October 21, 2026, including sales of $13.013 billion, reported sales growth of 14.5 percent and adjusted diluted earnings per share of $1.42, according to PR Newswire. The company reaffirmed its full-year 2026 adjusted diluted earnings-per-share guidance and tightened the range to $5.50 to $5.55.

Abbott Laboratories stock was at EUR 92.39 in weekend trading at Lang & Schwarz at 5:09 p.m. CEST on October 25, 2026. That was EUR 0.51, or 0.56 percent, above the Xetra close of October 23, 2026, at EUR 91.88.

Weekend trading

Lang & Schwarz showed a bid of EUR 92.20 and an ask of EUR 92.58 at the quoted time. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Abbott Laboratories stock.

Results and guidance

The October 21 release said comparable sales increased 7.0 percent in the third quarter of 2026. Abbott projected full-year 2026 comparable sales growth of approximately 6.0 percent and fourth-quarter 2026 adjusted diluted earnings per share of $1.62 to $1.67, as reported by PR Newswire.